ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      USA Passive

      iShares U.S. Medical Devices ETF

      The iShares U.S. Medical Devices ETF (the ¡°Fund¡±) seeks to track the investment results of an index composed of U.S. equities in the medical devices sector.

      $62.44

      Compare similar ETFs

      Fund Size
      Dividend
      Fees
      Current
      U.S. Medical Devices ETF IHI
      Fund Size
      $4.72B
      Dividend
      0.4%
      Fees
      0.39%
      Core S&P 500 ETF IVV
      Fund Size
      $626B
      Dividend
      1.2%
      Fees
      0.03%
      Core U.S. Aggregate Bond ETF AGG
      Fund Size
      $128B
      Dividend
      3.8%
      Fees
      0.03%
      S&P 500 Equal Weight ETF RSP
      Fund Size
      $73B
      Dividend
      1.5%
      Fees
      -
      Schwab U.S. Dividend Equity ETF SCHD
      Fund Size
      $68.2B
      Dividend
      3.7%
      Fees
      0.06%
      View 400 similar ETFs →

      Average metrics of all companies in portfolio

      Compare to
      Market
      Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $86.8B
      Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.37 %
      Beta Indicates the relationship between the price performance of a share and the market. 1.0416
      P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 49.82
      Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -45.79
      Profitable Companies 91
      PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 575.63
      Price to Sales Ratio Market cap divided by the revenue in the most recent year. 9.33
      Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 8.41
      Compare to
      Market
      Enterprise Value to EBIT Enterprise Value divided by EBIT 44.45
      Enterprise Value to Revenue Enterprise value divided by revenue 9.47
      Total Debt to Enterprise Value Total debt divided by enterprise value 0.09
      Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. NaN
      Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 18.29%
      Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
      Return on Equity Equity divided by market cap. 13.54%
      Return on Assets Indicates a company's profitability in relation to its total assets. 9.53%
      Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 12.32%

      Industries

      Healthcare 70.6%
      Technology 3.9%
      Industrials 2.0%
      Other 2.0%
      N/A 21.6%

      Market cap

      Micro Cap 0%
      Small Cap 2%
      Mid Cap 8%
      Large Cap 89%
      Mega Cap 0%

      51 Investments

      P/E-Ratio
      Total Investment
      Weight
      ABBOTT LABORATORIES logo

      ABBOTT LABORATORIES

      P/E-Ratio
      n/a
      Total Investment
      $869M
      Weight
      18.8%
      INTUITIVE SURGICAL, INC. logo

      ISRG - Manufacturing

      INTUITIVE SURGICAL, INC.

      P/E-Ratio
      65.1
      Total Investment
      $715M
      Weight
      15.5%
      BOSTON SCIENTIFIC CORPORATION logo

      BSX - Manufacturing

      BOSTON SCIENTIFIC CORPORATION

      P/E-Ratio
      62.3
      Total Investment
      $518M
      Weight
      11.2%
      STRYKER CORPORATION logo

      SYK - Manufacturing

      STRYKER CORPORATION

      P/E-Ratio
      51.3
      Total Investment
      $211M
      Weight
      4.6%
      EDWARDS LIFESCIENCES CORPORATION logo

      EW - Manufacturing

      EDWARDS LIFESCIENCES CORPORATION

      P/E-Ratio
      11.5
      Total Investment
      $210M
      Weight
      4.6%
      IDEXX LABORATORIES, INC. logo

      IDXX - Manufacturing

      IDEXX LABORATORIES, INC.

      P/E-Ratio
      52.8
      Total Investment
      $208M
      Weight
      4.5%
      BECTON, DICKINSON AND COMPANY logo

      BDX - Manufacturing

      BECTON, DICKINSON AND COMPANY

      P/E-Ratio
      34.6
      Total Investment
      $203M
      Weight
      4.4%
      MEDTRONIC PUBLIC LIMITED COMPANY logo

      MEDTRONIC PUBLIC LIMITED COMPANY

      P/E-Ratio
      n/a
      Total Investment
      $201M
      Weight
      4.4%
      RESMED INC. logo

      RMD - Manufacturing

      RESMED INC.

      P/E-Ratio
      28.7
      Total Investment
      $198M
      Weight
      4.3%
      DEXCOM, INC. logo

      DXCM - Manufacturing

      DEXCOM, INC.

      P/E-Ratio
      51.7
      Total Investment
      $179M
      Weight
      3.9%
      GE HEALTHCARE TECHNOLOGIES INC. logo

      GEHC

      GE HEALTHCARE TECHNOLOGIES INC.

      P/E-Ratio
      26.4
      Total Investment
      $178M
      Weight
      3.9%
      STERIS PUBLIC LIMITED COMPANY logo

      STERIS PUBLIC LIMITED COMPANY

      P/E-Ratio
      n/a
      Total Investment
      $124M
      Weight
      2.7%
      INSULET CORPORATION logo

      PODD - Manufacturing

      INSULET CORPORATION

      P/E-Ratio
      101.2
      Total Investment
      $116M
      Weight
      2.5%
      BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares logo

      BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares

      P/E-Ratio
      n/a
      Total Investment
      $101M
      Weight
      2.2%
      ZIMMER BIOMET HOLDINGS, INC. logo

      ZBH - Manufacturing

      ZIMMER BIOMET HOLDINGS, INC.

      P/E-Ratio
      25.5
      Total Investment
      $94.6M
      Weight
      2.0%
      BAXTER INTERNATIONAL INC. logo

      BAX - Manufacturing

      BAXTER INTERNATIONAL INC.

      P/E-Ratio
      -81.7
      Total Investment
      $81.5M
      Weight
      1.8%
      HOLOGIC, INC. logo

      HOLX - Manufacturing

      HOLOGIC, INC.

      P/E-Ratio
      27.0
      Total Investment
      $76.1M
      Weight
      1.6%
      PENUMBRA, INC. logo

      PEN - Manufacturing

      PENUMBRA, INC.

      P/E-Ratio
      71.7
      Total Investment
      $52.1M
      Weight
      1.1%
      MASIMO CORPORATION logo

      MASI - Manufacturing

      MASIMO CORPORATION

      P/E-Ratio
      -16.4
      Total Investment
      $39.7M
      Weight
      0.9%
      GLOBUS MEDICAL, INC. logo

      GMED - Manufacturing

      GLOBUS MEDICAL, INC.

      P/E-Ratio
      23.2
      Total Investment
      $35M
      Weight
      0.8%
      GLAUKOS CORPORATION logo

      GKOS - Manufacturing

      GLAUKOS CORPORATION

      P/E-Ratio
      -58.8
      Total Investment
      $30.9M
      Weight
      0.7%
      TELEFLEX INCORPORATED logo

      TFX - Manufacturing

      TELEFLEX INCORPORATED

      P/E-Ratio
      30.5
      Total Investment
      $27.4M
      Weight
      0.6%
      IRHYTHM TECHNOLOGIES, INC. logo

      IRTC - Manufacturing

      IRHYTHM TECHNOLOGIES, INC.

      P/E-Ratio
      -57.7
      Total Investment
      $25.8M
      Weight
      0.6%
      TRANSMEDICS GROUP, INC. logo

      TMDX - Manufacturing

      TRANSMEDICS GROUP, INC.

      P/E-Ratio
      54.4
      Total Investment
      $23.8M
      Weight
      0.5%
      INTEGER HOLDINGS CORPORATION logo

      ITGR - Manufacturing

      INTEGER HOLDINGS CORPORATION

      P/E-Ratio
      45.7
      Total Investment
      $22.5M
      Weight
      0.5%
      HoMEÔçÒÒŮѸÀ×